Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Surgical Technique

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06426420Not ApplicableUnknown

Endometriosis and ATR-FTIR Spectroscopy

NCT02669628CompletedPrimary

Antimullerian Hormone in Endometriomas

Showing all 2 trials

Research Network

Common Treatments

  • Surgical Technique1
  • Ftir Spectroscopy Analysis1
  • Alcohol Sclerotherapy1

Active Sponsors

  • Roche Diagnostic Ltd.1
  • Hospital Universitari de Bellvitge1
  • Federal University of Espirito Santo1
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico1

Top Investigators

Related Conditions

  • Endometriosis1

Activity Timeline